Skip to content
10-K

Annual Report

UNIGENE LABORATORIES INC

0001437749-13-002943

← back to feed
Filed
Mar 15, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Feb 28, 2013 95.98M sh
Capex FY 2012 · Dec 31, 2012 $236.36K
Operating Cash Flow FY 2012 · Dec 31, 2012 −$3.18M
Long Term Debt FY 2012 · Dec 31, 2012 $56.36M
Long Term Debt FY 2012 · Dec 31, 2011 $47.42M
Short Term Debt FY 2012 · Dec 31, 2012 $76.9M
Cash And Equivalents FY 2012 · Dec 31, 2012 $3.81M
Stockholders Equity FY 2012 · Dec 31, 2012 −$98.74M
Current Liabilities FY 2012 · Dec 31, 2012 $104.46M
Total Liabilities FY 2012 · Dec 31, 2012 $110.05M
Current Assets FY 2012 · Dec 31, 2012 $5.64M
Total Assets FY 2012 · Dec 31, 2012 $11.31M
Sga Expense FY 2012 · Dec 31, 2012 $8.55M
Rd Expense FY 2012 · Dec 31, 2012 $5.31M
Net Income FY 2012 · Dec 31, 2012 −$34.29M
Operating Income FY 2012 · Dec 31, 2012 −$9.37M
Cost Of Revenue FY 2012 · Dec 31, 2012 $1.64M
Revenue FY 2012 · Dec 31, 2012 $9.44M